Health Care Access & Coverage | Health Equity

Drug Pricing: Policy and Politics

Virtual Conversation with Benedic N. Ippolito, PhD, Rachel Sachs, JD, MPH, and Mariana Socal, MD, PhD, moderated by Rachel M. Werner, MD, PhD

12:00p.m. – 1:00p.m. ET September 17, 2021 Virtual Event

Despite bipartisan agreement that the high cost of drugs must be addressed, proposals to reform the U.S. drug pricing system have languished for years. There’s no shortage of ideas on what to do—Medicare price negotiation, greater price transparency, international reference pricing, patent exclusivity changes, and price controls all have their advocates. But there’s no consensus on how to strike the right balance between making drugs affordable now, and preserving financial incentives for developing new drugs in the future. Our expert panel discussed the policy options for drug pricing, the appropriate roles of government and markets, and prospects for reform in the current political environment. 

Supported by the Charles C. Leighton, MD Memorial Lecture Fund. 


Benedic N. Ippolito

Benedic N. Ippolito, PhD

Senior Fellow, Economic Policy Studies, American Enterprise Institute

Rachel Sachs

Rachel Sachs, JD, MPH

Professor of Law, Washington University School of Law

Mariana Socal

Mariana Socal, MD, PhD

Associate Scientist, Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health

Rachel M. Werner

Rachel M. Werner, MD, PhD (moderator)

Executive Director, Penn LDI; Robert D. Eilers Professor, Medicine and Health Care Management, Perelman School of Medicine and the Wharton School

Event Access Info

Please click the link below to join the webinar:

Webinar ID:
921 4275 3510


+13017158592, 92142753510# 

+13126266799, 92142753510#


+1 301 715 8592

+1 646 558 8656 

International numbers available:

H.323/SIP room system: (U.S. West) (U.S. East)

    Meeting ID: 921 4275 3510